Xeris Biopharma Inc. (XERS)
undefined
undefined%
At close: undefined
3.30
1.07%
Pre-market Dec 16, 2024, 07:13 AM EST

Xeris Biopharma Inc. Forcast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for XERS stock have an median target of 5, with a low estimate of 3 and a high estimate of 6.6. The median target predicts an increase of 52.91% from the current stock price of 3.27.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3 $4.87 $5 $6.6
Change -8.26% 48.93% 52.91% 101.83%

AI Analyst Report

HC Wainwright & Co. reaffirmed a Buy rating for Xe... Unlock content with Pro Subscription

Updated Nov 11, 2024

Rating Mar 24May 24Aug 24Nov 24
Strong Buy 1001
Buy 1210
Hold 0001
Sell 0000
Strong Sell 0000
Total 2 2 1 2

Financial Forecast this Year

Revenue This Year
220.36M
from 163.91M
Increased by 34.4%
Revenue Next Year
262.69M
from 220.36M
Increased by 19.2%
EPS This Year
-0.21
from -0.45
Increased by 53.3%
EPS Next Year
0.06
from -0.21
Increased by 71.4%